- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02042417
Comparison of POC-test-equipment With the Laboratory
Comparison of POC-test-equipment With the Standard Method (Laboratory) at ICU-patients
We compare two POC-tests (INRario2 and CoaguChek) for the INR with the laboratory. Therefore, we take bloodsamples (capillary and venous blood) and put it on the tool. After the measuring, a number is shown = INR.
We develop a Bland-Altman-plot for the correlation between the tool value and the laboratory value to illustrate the applicability in the clinical daily routine.
Study Overview
Detailed Description
Study Type
Phase
- Phase 4
Contacts and Locations
Study Contact
- Name: Reinhard Hahn, MD
- Phone Number: +431 40400
- Email: reinhard.hahn@meduniwien.ac.at
Study Locations
-
-
-
Vienna, Austria, 1090
- MUVienna
-
Contact:
- Reinhard Hahn, MD
- Phone Number: +43 1 40400
- Email: reinhard.hahn@meduniwien.ac.at
-
Contact:
- Nitaya Lebl
- Email: n0942382@students.meduniwien.ac.at
-
Principal Investigator:
- Reinhard Hahn, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
18-99 years, ICU patients
Exclusion Criteria:
Lupus erythematodes Anti-Phospholipid-Antikörper
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: INRatio2 and CoaguChek
one measuring per tool, in case of error: one repetiton
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Comparison of POC-test-equipment with the standard method (laboratory) at ICU-patients
Time Frame: 12 months
|
outcome measure: Bland Altman plot
|
12 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- INRatio_CoaguChek
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on INR-POC-testing
-
Michael HoelscherClinton Health Access Initiative Inc.; Instituto Nacional de Saúde (INS), Ministério... and other collaboratorsActive, not recruitingHIV, Neonatal HIV Early-Infant-Diagnosis (EID), Point-of-Care Testing (PoC)Mozambique, Tanzania
-
University of South FloridaCompletedAnticoagulation | Home INR Monitoring
-
University of ArkansasCentral Arkansas Veterans Healthcare SystemCompletedStable Target INRUnited States
-
Mansoura UniversityUnknownBlood Coagulation Tests ( INR, APTT)Egypt
-
MedicalpsIcadom; AG2R La Mondiale; AVALUN; ORIADE NOVIALE; SIL-LAB INNOVATIONS; TASDACompletedVitamine K Antagonist (VKA) Treatment | International Normalized Ratio (INR) Measure at Home | Thromboembolic PathologyFrance
-
University of TurkuAalto UniversityCompleted
-
Universitaire Ziekenhuizen KU LeuvenKU LeuvenUnknown
-
Centre Hospitalier Universitaire VaudoisNot yet recruitingPharmacogenetic Testing
-
RTI InternationalUniversity of FloridaNot yet recruiting
Clinical Trials on INRatio2 and CoaguChek
-
Medical University of ViennaCompletedIntraventricular Haemorrhage | Pulmonary HaemorrhageAustria
-
Hoffmann-La RocheWithdrawnCardiovascular AbnormalitiesCanada
-
Hospital de BaseNot yet recruitingCoaguChek® XS System | Coagulation Function
-
Nationwide Children's HospitalCompletedCardiopulmonary Bypass | Spinal FusionUnited States
-
University College CorkHoffmann-La Roche; Health Research Board, Ireland; ZyCare IncUnknown
-
Montreal Heart InstituteRoche Diagnostic Ltd.CompletedQuality of Life | Anticoagulants | Drug Monitoring | Pharmacy | Ambulatory CareCanada
-
University of FloridaHoffmann-La RocheCompletedAntiphospholipid Antibody SyndromeUnited States
-
University of UlsterBelfast Health and Social Care TrustCompletedCongenital Heart Disease | Congenital Heart Defect | Adult Congenital Heart DiseaseUnited Kingdom
-
University Hospital, BordeauxHoffmann-La Roche; Ministry of Health, France; BiodisCompletedMechanical Prosthetic Heart Valve Implantation | Patient Self Monitoring of Oral Anticoagulent TherapyFrance
-
Shenzhen Geno-Immune Medical InstituteUnknown